Clinical Trial: A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
Study Status: Completed
Recruit Status: RECRUITING
Condition: Multiple Myeloma
Study Type: OBSERVATIONAL
Official Title: Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD
Brief Summary:
This is an observational study that will include both participants with relapsed/refractory Multiple Myeloma and their doctors.The purpose of this study is to gather information about the use of hematopoietic cell transplantation/HCT and B-cell maturation antigen /BCMS targeted chimeric antigen receptor/CAR autologous T-cell therapy.
Read more